$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Dietary taboos and life adjustment suggestions while taking cycloserine
2026-02-01 22:25:32
Check Details
In-depth analysis of cycloserine safety: pharmacology, side effects, contraindications and usage guidelines for special groups
2026-02-01 22:25:32
Check Details
Tucatinib (Tucatinib) launch time in China
2026-02-01 22:25:32
Check Details
How much does tucatinib cost per month?
2026-02-01 22:25:32
Check Details
What will be the effects of not taking Bituvit for three days?
2026-02-01 22:25:32
Check Details
Do I need to retake Bituvi if I forget to take it 8 hours ago?
2026-02-01 22:25:32
Check Details
What impact does Bituvit have on the lifespan of AIDS patients?
2026-02-01 22:25:32
Check Details
Is there any chance of blocking failure when taking Bituvi?
2026-02-01 22:25:32
Check Details
What are the side effects of Bituvi?
2026-02-01 22:25:32
Check Details
How effective is Bituvi in u200bu200bblocking AIDS?
2026-02-01 22:25:32
Check Details
Precautions while taking Bituvi
2026-02-01 22:25:32
Check Details
Fenelidone: the difference between new non-steroidal MRAs and traditional hormonal drugs
2026-02-01 22:25:32
Check Details
1
2
...
910
911
912
913
914
915
916
...
10238
10239
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ramosetron ODT for IBS-D: Gender-Based Dosing and Treatment Review
2
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
3
Acoramidis for ATTR-CM: TTR Stabilizer to Reduce CV Death and Hospitalization
4
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
5
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
6
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
7
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
8
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
9
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB
10
Pacritinib Drug Contraindications and Precautions
11
Pomalidomide Side Effects, Risk Monitoring, and Precautions
12
Dasatinib for Ph+ Chronic Myeloid Leukemia: Dosage, Administration, and Long-Term Care